Sernova Corp. (OTCMKTS:SEOVF – Get Free Report) saw a large drop in short interest in the month of April. As of April 15th, there was short interest totalling 1,900 shares, a drop of 98.2% from the March 31st total of 106,700 shares. Based on an average trading volume of 41,900 shares, the days-to-cover ratio is currently 0.0 days.
Sernova Trading Up 2.9 %
Shares of SEOVF stock traded up $0.01 on Friday, reaching $0.32. 14,800 shares of the stock were exchanged, compared to its average volume of 19,347. The company has a quick ratio of 1.20, a current ratio of 1.20 and a debt-to-equity ratio of 0.14. The stock has a market cap of $96.64 million, a P/E ratio of -3.54 and a beta of 1.16. The firm has a 50 day moving average of $0.40 and a two-hundred day moving average of $0.47. Sernova has a 1-year low of $0.29 and a 1-year high of $0.83.
Sernova (OTCMKTS:SEOVF – Get Free Report) last announced its quarterly earnings results on Monday, March 18th. The company reported ($0.02) earnings per share for the quarter.
Analyst Ratings Changes
Read Our Latest Stock Report on SEOVF
About Sernova
Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.
See Also
- Five stocks we like better than Sernova
- Airline Stocks – Top Airline Stocks to Buy Now
- 3 Stocks Leading the U.S. Agriculture Comeback
- How to buy stock: A step-by-step guide for beginners
- How to Use Put Debit Spreads to Profit From Falling Stocks
- Roth IRA Calculator: Calculate Your Potential Returns
- Alphabet Changes the Narrative with Its First-Ever Dividend
Receive News & Ratings for Sernova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova and related companies with MarketBeat.com's FREE daily email newsletter.